Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00786201
What this trial is testing

Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
Centocor, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT05537025
What this trial is testing

Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Arrowhead Pharmaceuticals 105
Large-scale testing (Phase 3)Not Yet RecruitingNCT07520110
What this trial is testing

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Massachusetts, Worcester 800
Not applicableStudy completedNCT04586946
What this trial is testing

FIBRotic Interstitial Lung Disease and Nocturnal OXygen

Who this might be right for
Idiopathic Pulmonary FibrosisObstructive Sleep ApneaSleep Disturbance+1 more
Guy's and St Thomas' NHS Foundation Trust 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT07036523
What this trial is testing

Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 81
Not applicableStudy completedNCT01110694
What this trial is testing

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study

Who this might be right for
Idiopathic Pulmonary FibrosisIdiopathic Non-specific Interstitial Pneumonitis
Royal Brompton & Harefield NHS Foundation Trust 230
Not applicableStudy completedNCT04775277
What this trial is testing

Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sohag University 63
Not applicableStudy completedNCT04177251
What this trial is testing

Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisCardiac FibrosisArterial Fibrosis
San Gerardo Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00703339
What this trial is testing

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Lung Biotechnology PBC 1
Large-scale testing (Phase 3)Study completedNCT00631475
What this trial is testing

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Who this might be right for
Idiopathic Pulmonary Fibrosis
Actelion 128
Testing effectiveness (Phase 2)Ended earlyNCT03573505
What this trial is testing

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Biogen 109
Testing effectiveness (Phase 2)Study completedNCT00514683
What this trial is testing

Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 432
Testing effectiveness (Phase 2)UnknownNCT05373914
What this trial is testing

RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Blade Therapeutics 200
Not applicableLooking for participantsNCT05989698
What this trial is testing

Validation of the C-mo System - Cough Monitoring

Who this might be right for
CoughAsthmaChronic Obstructive Pulmonary Disease+5 more
Cough Monitoring Medical Solutions 300
Testing effectiveness (Phase 2)UnknownNCT06102083
What this trial is testing

A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Beijing Tide Pharmaceutical Co., Ltd 120
Not applicableNot Yet RecruitingNCT07019714
What this trial is testing

Daoyin Technique for Improving Exercise Endurance in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine 236
Not applicableActive Not RecruitingNCT02951416
What this trial is testing

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

Who this might be right for
Idiopathic Pulmonary FibrosisIdiopathic Interstitial PneumoniaInterstitial Lung Diseases+1 more
Andreas Guenther 2,000
Testing effectiveness (Phase 2)Study completedNCT05621252
What this trial is testing

Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 10
Not applicableNo Longer AvailableNCT02230982
What this trial is testing

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim
Not applicableNot Yet RecruitingNCT06668051
What this trial is testing

Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHealthy
Hacettepe University 24
Next Page